Patents Assigned to RESET PHARMACEUTICALS, INC.
  • Co-crystals or salts of psilocin and methods of treatment therewith
    Patent number: 12559458
    Abstract: The invention relates to a co-crystal or salt comprising psilocin and a co-former. The co-crystal or salt is useful in methods of treating or preventing a disease or condition selected from depression, anxiety, death anxiety, demoralization, adjustment disorders, hopelessness, suicidal ideation, desire for hastened death, cocaine-related disorders, opioid-related disorders and stimulant-related disorders in a patient. A kit comprising the co-crystal or salt is also described.
    Type: Grant
    Filed: March 3, 2023
    Date of Patent: February 24, 2026
    Assignee: RESET PHARMACEUTICALS, INC.
    Inventors: John Knight, Talbir Austin
  • Co-crystals or salts of psilocybin and methods of treatment therewith
    Patent number: 12060328
    Abstract: The invention relates to a co-crystal or salt comprising psilocybin and a co-former. The co-crystal or salt is useful in methods of treating or preventing a disease or condition selected from depression, anxiety, death anxiety, demoralization, adjustment disorders, hopelessness, suicidal ideation, desire for hastened death, cocaine-related disorders, opioid-related disorders and stimulant-related disorders in a patient. A kit comprising the co-crystal or salt is also described.
    Type: Grant
    Filed: March 3, 2023
    Date of Patent: August 13, 2024
    Assignee: RESET PHARMACEUTICALS, INC.
    Inventors: John Knight, Talbir Austin